Skip to content

Drug interactions

Irinotecan + Safinamide

Severity: Moderate

Irinotecan and Safinamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Irinotecan and its active metabolite SN-38 are BCRP substrates, and inhibition of BCRP by safinamide may increase exposure. Because irinotecan is given intravenously, the effect is likely modest. Higher SN-38 exposure could worsen diarrhea and neutropenia.

What this interaction means in plain words

Irinotecan and Safinamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Irinotecan belongs to Oncology; Safinamide belongs to Central Nervous System.

Evidence level: Low

Why it happens

Safinamide inhibits BCRP, which may reduce efflux and clearance of SN-38 and irinotecan.

What to do

Monitor for severe diarrhea and neutropenia during irinotecan cycles. Manage toxicity per standard protocols and reduce the irinotecan dose if needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irinotecan and Safinamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irinotecan with Safinamide?

MediHelp rates the interaction as moderate. Irinotecan and Safinamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Irinotecan and its active metabolite SN-38 are BCRP substrates, and inhibition of BCRP by safinamide may increase exposure. Because irinotecan is given intravenously, the effect is likely modest. Higher SN-38 exposure could worsen diarrhea and neutropenia.

How serious is the interaction between Irinotecan and Safinamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for severe diarrhea and neutropenia during irinotecan cycles. Manage toxicity per standard protocols and reduce the irinotecan dose if needed.

What other medicines interact with Safinamide?

MediHelp also lists interactions of Safinamide with, for example, Amitriptyline, Amoxapine, Amphetamine polistirex. The full list is on the Safinamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in